|
Miltenyi Biotec
β1 detection ![]() β1 Detection, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/10__1016_slash_j__snb__2019__126954-114-21-23?v=Miltenyi+Biotec Average 93 stars, based on 1 article reviews
β1 detection - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
hms1 1 ![]() Hms1 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pmc06760463-0-4-8?v=Miltenyi+Biotec Average 93 stars, based on 1 article reviews
hms1 1 - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
OriGene
rnai ![]() Rnai, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pm20101206-220-5-7?v=OriGene Average 90 stars, based on 1 article reviews
rnai - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Proteintech
rabbit anti itgb1 ![]() Rabbit Anti Itgb1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pmc13013605-502-103-105?v=Proteintech Average 96 stars, based on 1 article reviews
rabbit anti itgb1 - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
Addgene inc
itgb1 ![]() Itgb1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pm39706188-544-9-30?v=Addgene+inc Average 93 stars, based on 1 article reviews
itgb1 - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
Boster Bio
anti integrin beta 1 ![]() Anti Integrin Beta 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pm41815940-106-13-18?v=Boster+Bio Average 90 stars, based on 1 article reviews
anti integrin beta 1 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
anti cd29 ![]() Anti Cd29, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pmc10340470-89-12-13?v=Miltenyi+Biotec Average 93 stars, based on 1 article reviews
anti cd29 - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
Addgene inc
human cea3 itgb chimeras ![]() Human Cea3 Itgb Chimeras, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pmc06450878-204-5-12?v=Addgene+inc Average 90 stars, based on 1 article reviews
human cea3 itgb chimeras - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
OriGene
shrna itgb1 ![]() Shrna Itgb1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pmc03149042-255-30-31?v=OriGene Average 90 stars, based on 1 article reviews
shrna itgb1 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
OriGene
integrin β1 sirna ![]() Integrin β1 Sirna, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pm31598171-61-16-39?v=OriGene Average 90 stars, based on 1 article reviews
integrin β1 sirna - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
OriGene
cd29 fitz ![]() Cd29 Fitz, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pmc03875213-99-17-20?v=OriGene Average 90 stars, based on 1 article reviews
cd29 fitz - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
OriGene
integrin β1myc ddk ![]() Integrin β1myc Ddk, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/itgb1/pm28617578__cb7b00305_si_001-59-10-21?v=OriGene Average 93 stars, based on 1 article reviews
integrin β1myc ddk - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Sensors and Actuators B: Chemical
Article Title: Extracellular matrix protein microarray-based biosensor with single cell resolution: Integrin profiling and characterization of cell-biomaterial interactions
doi: 10.1016/j.snb.2019.126954
Figure Lengend Snippet: Fig. 1. Protein microarray biosensor development. (A) Scheme of the
Article Snippet: A suspension of 106 cells was dyed for 10 min at 4 oC in the dark with human CD29-PEVIO770 antibodies for
Techniques: Microarray
Journal: Developmental cell
Article Title: Global versus local matrix remodeling drives rotational versus invasive collective migration of epithelial cells.
doi: 10.1016/j.devcel.2024.11.021
Figure Lengend Snippet: Figure 5. ICM but not RCM is dependent on MMP-mediated matrix remodeling (A and B) Frequencies of ductal-like and acinus-like morphologies at 7 days in vehicle- and MMPi-treated (A) MDA-MB-231 (n = 217 multicellular structures and n = 192 multicellular structures for vehicle and MMP-treated conditions, respectively) and (B) SK-HEP-1 cell lines (n = 207 multicellular structures and n = 220 multicellular structures for vehicle and MMP-treated conditions, respectively). (C and D) Average angular speed per cellular track of vehicle- and MMPi-treated (C) MDA-MB-231 (n = 18 individual cells, n = 9 cell clusters per treatment condition) and (D) SK-HEP-1 cells in 2-cell clusters (n = 8 individual cells, n = 4 cell clusters per treatment condition). (E and F) Cell persistence ratio per cellular track for vehicle- and MMPi-treated (E) MDA-MB-231 (n = 18 individual cells, n = 9 cell clusters per treatment condition) and (F) SK-HEP-1 cells in 2- cell clusters (n = 8 individual cells, n = 4 cell clusters per treatment condition). (G) Time-lapse images of circular 2-cell clusters of SK-HEP-1 MMPi-treated cells reveals persistent rotational migration. Scale bar, 10 mm. (H and I) Quantification of (H) pericellular matrix-remodeling intensity and (I) % pericellular matrix remodeling, as measured by DQ-collagen I. (J) Quantification of MMP-dependent remodeling, using the collagen 3=4 antibody specific to MMP-cleaved collagen I (n = 15 cells per condition were analyzed from three independent biological replicates). (K) Representative fluorescent micrographs show matrix remodeling of vehicle-treated invasive and rotational and MMPi-treated rotational MDA-MB-231 cells, as measured by DQ-collagen I and collagen 3=4 antibody. Scale bar, 10 mm. (L) Representative fluorescent micrographs show MT1-MMP and ITGb1 signal distribution in vehicle-treated invasive and rotational and MMPi-treated rotational MDA-MB-231 cells. Scale bar, 25 mm. (M and N) Quantification of (M) MT1-MMP and (N) ITGb1 signal distribution along pericellular membranes of vehicle-treated invasive and rotational and MMPi-treated rotational MDA-MB-231 cells, as quantified by MT1-MMP signal distribution skewness (n = 14–15 cells per condition were analyzed from three independent biological replicates). (O–Q) Quantification of (O) maximum protrusion length, (P) average protrusion lifetime, and (Q) protrusion formation rate, as measured by mCherry-LifeAct. (R–T) Quantification of (R) average maximum bead displacement, (S) average % moving beads, and (T) bead speed, as measured by traction force beads. For graphs (H, I, and O–T) n = 9–10 cells were analyzed per condition. All error bars represent standard deviation from the mean. Statistical significance is indicated as ns, not significant, (*) p % 0.05, (**) p % 0.01, (***) p % 0.001, and (****) p % 0.0001.
Article Snippet: CRISPR-Cas9 mediated gene suppression of ITGb1 Genetic knockdown of
Techniques: Migration, Standard Deviation
Journal: Developmental cell
Article Title: Global versus local matrix remodeling drives rotational versus invasive collective migration of epithelial cells.
doi: 10.1016/j.devcel.2024.11.021
Figure Lengend Snippet: Figure 6. RCM relies on ITGb1 (A) Western blot assessment of ITGb1 depletion in MDA-MB-231 cell line. (B) Frequencies of ductal-like and acinus-like morphologies at 7 days in WT and crITGb1 MDA-MB-231 cells (n = 139 multicellular structures and n = 141 multicellular structures for WT and crITGb1 cell lines, respectively). (C) Polar plots of rounded 2-cell clusters of MDA-MB-231 crITGb1 cells (n = 6 individual cells, n = 3 cell clusters), and color indicates cluster pair. (D) Representative fluorescent micrographs show matrix-remodeling localization at 48 h of rounded WT and crITGb1 MDA-MB-231 cells, as measured by DQ-collagen I. Scale bar, 10 mm. (E) Quantification of pericellular matrix-remodeling intensity, as measured by DQ-collagen I (n = 15 cells for all WT conditions, n = 25 for all crITGb1 conditions). (F) Western blot assessment MT1-MMP expression in MDA-MB-231 WT and crITGb1 cells. Values on blot indicate quantified relative MT1-MMP expression. (G) Quantification of MMP-dependent remodeling, using the collagen 3=4 antibody specific to MMP-cleaved collagen I. n = 15 cells for all WT conditions, n = 25 for all crITGb1 conditions. All error bars represent standard deviation from the mean. (H and I) Histology of whole-mount mammary glands from 6.5-week-old mice treated daily with (H) vehicle or (I) GM-6001 broad-spectrum MMP inhibitor from 3.5 weeks old reveals increased lateral budding in GM6001-treated mammary glands. Scale bar, 1 mm. Image reproduced with permission: ª2003 Wiseman et al.44 Originally published in Journal of Cell Biology. https://doi.org/10.1083/jcb. 200302090 as Figures 2a and 2b. (J) Histology of mammary tissue from wild-type control (left column) and Col1a1tm1Jae (right column) mice showing increased prevalence of spheroid structures (arrows) in Col1a1tm1Jae mammary tissue. Collagen surrounding the mammary duct is detected with H&E, trichrome, and picrosirius red staining. Images taken from Provenzano et al.46 Figures 3a and 3c and Supplementary Figures 2a and 2b, which was published in BMC Medicine in 2006 with a Creative Commons CC BY license (https://doi.org/10.1186/1741-7015-4-38). Statistical significance is indicated as ns, not significant, (*) p % 0.05, (**) p % 0.01, (***) p % 0.001, and (****) p % 0.0001.
Article Snippet: CRISPR-Cas9 mediated gene suppression of ITGb1 Genetic knockdown of
Techniques: Western Blot, Expressing, Standard Deviation, Control, Staining
Journal: Cells
Article Title: Methylglyoxal Impairs the Pro-Angiogenic Ability of Mouse Adipose-Derived Stem Cells (mADSCs) via a Senescence-Associated Mechanism
doi: 10.3390/cells12131741
Figure Lengend Snippet: mADSCs characterization. ( a ) Representative photographs (5× magnification of an optical microscope, scale bar 500 µm) of mADSCs isolated from the subcutaneous adipose tissue of C57bl6 mice cultured in selection medium for 4 passages. ( b ) Accumulated cell number and ( c ) population doubling time (PTD) per hours of mADSCs from p3 to p11. Once 90% confluence was reached, cells were counted by an automated cell counter. Dots in line graphs represent the mean ± SEM values. ( d – i ) Representative histograms of the expression of CD44, CD29, CD90.2, Sca-1, CD45 and CD31 surface markers analyzed by FACS.
Article Snippet: Then, the cells were divided into 4 aliquots: (i) stained with APC-labeled
Techniques: Microscopy, Isolation, Cell Culture, Selection, Expressing
Journal: Journal of Cancer
Article Title: Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.
doi: 10.7150/jca.30772
Figure Lengend Snippet: Figure 1. The effect of GLUT1 on NSCLC cell proliferation and colony formation. (A, B) NSCLC cell proliferation; (C, D) NSCLC cell colony formation. Adding siRNA-GLUT1 (siGLUT1) to A549 cell and GLUT1 expression plasmid (GLUT1) to LK2 cell; the graph in (C) and (D) shows the number of colony formation under different treatments; *, P <0.05 compared with negative control; NC, negative control; si-NC, scramble siRNA for negative control; Error bars, S.D.
Article Snippet: GLUT1 siRNA and control siRNA were purchased from Santa Cruz Biotechnology (CA, USA; catalog number: sc-35493),
Techniques: Expressing, Plasmid Preparation, Negative Control
Journal: Journal of Cancer
Article Title: Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.
doi: 10.7150/jca.30772
Figure Lengend Snippet: Figure 2. The effect of GLUT1 on the cell cycle correlated proteins in NSCLC cells. We added siRNA-GLUT1 (siGLUT1) to A549 cell and GLUT1 expression plasmid (GLUT1) to LK2 cell; NC, negative control; si-NC, scramble siRNA for negative control.
Article Snippet: GLUT1 siRNA and control siRNA were purchased from Santa Cruz Biotechnology (CA, USA; catalog number: sc-35493),
Techniques: Expressing, Plasmid Preparation, Negative Control
Journal: Journal of Cancer
Article Title: Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.
doi: 10.7150/jca.30772
Figure Lengend Snippet: Figure 3. The effect of GLUT1 on NSCLC cell migration and correlated proteins. (A, B) NSCLC cell migration; (C, D) the expressions of ROCK1, ROCK2 and RhoA. We added siRNA-GLUT1 (siGLUT1) to A549 cell and GLUT1 expression plasmid (GLUT1) to LK2 cell; the graph in (A) and (B) shows the distance of cell migration under different treatments; *, P<0.05 compared with negative control; NC, negative control; si-NC, scramble siRNA for negative control; Error bars, S.D.
Article Snippet: GLUT1 siRNA and control siRNA were purchased from Santa Cruz Biotechnology (CA, USA; catalog number: sc-35493),
Techniques: Migration, Expressing, Plasmid Preparation, Negative Control
Journal: Journal of Cancer
Article Title: Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.
doi: 10.7150/jca.30772
Figure Lengend Snippet: Figure 4. The effect of GLUT1 on NSCLC cell invasion and correlated proteins. (A, B) NSCLC cell invasion; (C, D) the expressions of MMP2, proMMP2 and TIMP2. We added siRNA-GLUT1 (siGLUT1) to A549 cell and GLUT1 expression plasmid (GLUT1) to LK2 cell; the graph in (A) and (B) shows the number of invading cells under different treatments; *, P<0.05 compared with negative control; NC, negative control; si-NC, scramble siRNA for negative control; Error bars, S.D.
Article Snippet: GLUT1 siRNA and control siRNA were purchased from Santa Cruz Biotechnology (CA, USA; catalog number: sc-35493),
Techniques: Expressing, Plasmid Preparation, Negative Control
Journal: Journal of Cancer
Article Title: Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.
doi: 10.7150/jca.30772
Figure Lengend Snippet: Figure 5. The effect of GLUT1 on the apoptosis in A549 and LK2 cells. We added siRNA-GLUT1 (siGLUT1) to A549 cell (A) and GLUT1 expression plasmid (GLUT1) to LK2 cell (B); NC, negative control; si-NC, scramble siRNA for negative control.
Article Snippet: GLUT1 siRNA and control siRNA were purchased from Santa Cruz Biotechnology (CA, USA; catalog number: sc-35493),
Techniques: Expressing, Plasmid Preparation, Negative Control
Journal: Journal of Cancer
Article Title: Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.
doi: 10.7150/jca.30772
Figure Lengend Snippet: Figure 6. The effect of GLUT1 on integrin β1/Src/FAK signaling in NSCLC cells. We added siRNA-GLUT1 (siGLUT1) to A549 cell and GLUT1 expression plasmid (GLUT1) to LK2 cell; NC, negative control; si-NC, scramble siRNA for negative control.
Article Snippet: GLUT1 siRNA and control siRNA were purchased from Santa Cruz Biotechnology (CA, USA; catalog number: sc-35493),
Techniques: Expressing, Plasmid Preparation, Negative Control